These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis. Montesinos MC; Yap JS; Desai A; Posadas I; McCrary CT; Cronstein BN Arthritis Rheum; 2000 Mar; 43(3):656-63. PubMed ID: 10728760 [TBL] [Abstract][Full Text] [Related]
4. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis? Bird HA Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642 [TBL] [Abstract][Full Text] [Related]
5. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient. Ranganath VK; Furst DE Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212 [TBL] [Abstract][Full Text] [Related]
6. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. Gadangi P; Longaker M; Naime D; Levin RI; Recht PA; Montesinos MC; Buckley MT; Carlin G; Cronstein BN J Immunol; 1996 Mar; 156(5):1937-41. PubMed ID: 8596047 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis. Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression. Ochaion A; Bar-Yehuda S; Cohn S; Del Valle L; Perez-Liz G; Madi L; Barer F; Farbstein M; Fishman-Furman S; Reitblat T; Reitblat A; Amital H; Levi Y; Molad Y; Mader R; Tishler M; Langevitz P; Zabutti A; Fishman P Arthritis Res Ther; 2006; 8(6):R169. PubMed ID: 17101059 [TBL] [Abstract][Full Text] [Related]
10. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis. Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210 [TBL] [Abstract][Full Text] [Related]
11. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient. Ranganath VK; Furst DE Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700 [TBL] [Abstract][Full Text] [Related]
12. Differential influences of bucillamine and methotrexate on the generation of fibroblast-like cells from bone marrow CD34+ cells of rheumatoid arthritis patients. Hirohata S; Yanagida T; Tomita T; Yoshikawa H Int Immunopharmacol; 2009 Jan; 9(1):86-90. PubMed ID: 19000788 [TBL] [Abstract][Full Text] [Related]
13. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Tian H; Cronstein BN Bull NYU Hosp Jt Dis; 2007; 65(3):168-73. PubMed ID: 17922664 [TBL] [Abstract][Full Text] [Related]
14. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661 [TBL] [Abstract][Full Text] [Related]
15. Effects of methotrexate and salazosulfapyridine on protein profiles of exosomes derived from a human synovial sarcoma cell line of SW982. Tsuno H; Suematsu N; Sato T; Arito M; Matsui T; Iizuka N; Omoteyama K; Okamoto K; Tohma S; Kurokawa MS; Kato T Proteomics Clin Appl; 2016 Feb; 10(2):164-71. PubMed ID: 26172530 [TBL] [Abstract][Full Text] [Related]
16. Requirement of methotrexate in combination with anti-tumor necrosis factor-alpha therapy for adequate suppression of osteoclastogenesis in rheumatoid arthritis. Matsuno H; Yoshida K; Ochiai A; Okamoto M J Rheumatol; 2007 Dec; 34(12):2326-33. PubMed ID: 18050387 [TBL] [Abstract][Full Text] [Related]
17. Suppressive influences of methotrexate on the generation of CD14(+) monocyte-lineage cells from bone marrow of patients with rheumatoid arthritis. Hirohata S; Yanagida T; Hashimoto H; Tomita T; Ochi T Clin Immunol; 1999 Apr; 91(1):84-9. PubMed ID: 10219258 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes. Vergne P; Liagre B; Bertin P; Cook-Moreau J; Treves R; Beneytout JL; Rigaud M J Rheumatol; 1998 Mar; 25(3):433-40. PubMed ID: 9517759 [TBL] [Abstract][Full Text] [Related]
19. Methotrexate treatment suppresses local cytokine and chemokine production in rat adjuvant arthritis. Barsig J; Yam G; Lehner MD; Beume R Drugs Exp Clin Res; 2005; 31(1):7-11. PubMed ID: 15921024 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Gubar' EE; Bochkova AG; Bunchuk NV Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]